Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

DNA-directed DNAP inhibitor

DRUG CLASS:

DNA-directed DNAP inhibitor

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

cytarabine (99)

cytarabine (99)

›

No biomarker	Burkitt Lymphoma	No biomarker	Burkitt Lymphoma	cytarabine + methotrexate Sensitive: A2 - Guideline cytarabine + methotrexate Sensitive : A2	cytarabine + methotrexate Sensitive: A2 - Guideline cytarabine + methotrexate Sensitive : A2
No biomarker	Lymphoma	No biomarker	Lymphoma	cytarabine Sensitive: A2 - Guideline cytarabine Sensitive : A2	cytarabine Sensitive: A2 - Guideline cytarabine Sensitive : A2
No biomarker	Acute Lymphocytic Leukemia	No biomarker	Acute Lymphocytic Leukemia	cytarabine + methotrexate + idarubicin Sensitive: A2 - Guideline cytarabine + methotrexate + idarubicin Sensitive : A2	cytarabine + methotrexate + idarubicin Sensitive: A2 - Guideline cytarabine + methotrexate + idarubicin Sensitive : A2
No biomarker	Childhood B Acute Lymphoblastic Leukemia	No biomarker	Childhood B Acute Lymphoblastic Leukemia	cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive: A2 - Guideline cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive : A2	cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive: A2 - Guideline cytarabine + cyclophosphamide + methotrexate + vincristine + pegaspargase Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine Sensitive: A2 - Guideline cytarabine Sensitive : A2	cytarabine Sensitive: A2 - Guideline cytarabine Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + fludarabine IV + GCSF Sensitive: A2 - Guideline cytarabine + fludarabine IV + GCSF Sensitive : A2	cytarabine + fludarabine IV + GCSF Sensitive: A2 - Guideline cytarabine + fludarabine IV + GCSF Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + idarubicin hydrochloride + fludarabine IV + GCSF Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride + fludarabine IV + GCSF Sensitive : A2	cytarabine + idarubicin hydrochloride + fludarabine IV + GCSF Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride + fludarabine IV + GCSF Sensitive : A2
No biomarker	Acute Promyelocytic Leukemia	No biomarker	Acute Promyelocytic Leukemia	cytarabine + daunorubicin Sensitive: A2 - Guideline cytarabine + daunorubicin Sensitive : A2	cytarabine + daunorubicin Sensitive: A2 - Guideline cytarabine + daunorubicin Sensitive : A2
FLT3-TKD mutation	Acute Myelogenous Leukemia	FLT3-TKD mutation	Acute Myelogenous Leukemia	cytarabine + midostaurin + daunorubicin Sensitive: A2 - Guideline cytarabine + midostaurin + daunorubicin Sensitive : A2	cytarabine + midostaurin + daunorubicin Sensitive: A2 - Guideline cytarabine + midostaurin + daunorubicin Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + daunorubicin Sensitive: A2 - Guideline cytarabine + daunorubicin Sensitive : A2	cytarabine + daunorubicin Sensitive: A2 - Guideline cytarabine + daunorubicin Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + idarubicin hydrochloride Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride Sensitive : A2	cytarabine + idarubicin hydrochloride Sensitive: A2 - Guideline cytarabine + idarubicin hydrochloride Sensitive : A2
No biomarker	Acute Myelogenous Leukemia	No biomarker	Acute Myelogenous Leukemia	cytarabine + etoposide IV + mitoxantrone Sensitive: A2 - Guideline cytarabine + etoposide IV + mitoxantrone Sensitive : A2	cytarabine + etoposide IV + mitoxantrone Sensitive: A2 - Guideline cytarabine + etoposide IV + mitoxantrone Sensitive : A2